SPONSOR
Pharmicell Co., Ltd.
Total Trials
3
Recruiting
3
Phases
Phase 3
Pharmicell Co., Ltd. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Alcoholic Cirrhosis, Acute Myocardial Infarction.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Pharmicell Co., Ltd.
How many clinical trials has Pharmicell Co., Ltd. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Pharmicell Co., Ltd., of which 3 are actively recruiting participants. These trials cover conditions including Alcoholic Cirrhosis, Acute Myocardial Infarction. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Pharmicell Co., Ltd. research focus on?
Pharmicell Co., Ltd. clinical trials span Alcoholic Cirrhosis, Acute Myocardial Infarction. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Pharmicell Co., Ltd. clinical trial?
To participate in a Pharmicell Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Pharmicell Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Pharmicell Co., Ltd.
NCT04689152 Phase 3
Recruiting
Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis
Alcoholic Cirrhosis
NCT05093881
Recruiting
Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study
Alcoholic Cirrhosis
NCT07400458
Recruiting
Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration
Acute Myocardial Infarction
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology